Evidence map›Paper›PMID 27179730›Full record

SynthesisAmerican heart journal2016

Genetic loci associated with ideal cardiovascular health: A meta-analysis of genome-wide association studies.

Norrina B Allen, Donald Lloyd-Jones, Shih-Jen Hwang, Laura Rasmussen-Torvik, Myriam Fornage, Alanna C Morrison, Abigail S Baldridge, Eric Boerwinkle, Daniel Levy, L Adrienne Cupples and 11 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in American heart journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. FromJournal of the American Heart Association · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 2 countries.

Norrina B AllenDepartment of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL. Electronic address: Norrina-allen@northwestern.edu.
Donald Lloyd-JonesDepartment of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Shih-Jen HwangDivision of Intramural Research, National Heart, Lung and Blood Institute (NHLBI), Framingham, MA; NHLBI's Framingham Heart Study, Framingham, MA.
Laura Rasmussen-TorvikDepartment of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Myriam FornageHuman Genetics Center, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX.
Alanna C MorrisonHuman Genetics Center, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX.
Abigail S BaldridgeDepartment of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Eric BoerwinkleHuman Genetics Center, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX.
Daniel LevyDivision of Intramural Research, National Heart, Lung and Blood Institute (NHLBI), Framingham, MA; NHLBI's Framingham Heart Study, Framingham, MA.
L Adrienne CupplesNHLBI's Framingham Heart Study, Framingham, MA.
Caroline S FoxDivision of Intramural Research, National Heart, Lung and Blood Institute (NHLBI), Framingham, MA; NHLBI's Framingham Heart Study, Framingham, MA.
George ThanassoulisDepartment of Medicine and the Research Institute, Preventive and Genomic Cardiology, McGill University Health Center, Montreal, QC, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.
Line DufresneDepartment of Medicine and the Research Institute, Preventive and Genomic Cardiology, McGill University Health Center, Montreal, QC, Canada.
Martha DaviglusUniversity of Illinois, Chicago, IL.
Andrew D JohnsonDivision of Intramural Research, National Heart, Lung and Blood Institute (NHLBI), Framingham, MA; NHLBI's Framingham Heart Study, Framingham, MA.
Jared ReisNational Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Bethesda, MD.
Jerome RotterInstitute for Translational Genomics and Population Sciences, Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA.
Walter PalmasDepartment of Medicine, Columbia University, New York, NY.
Mathew AllisonDivision of Preventive Medicine, University of California, San Diego, CA.
James S PankowUniversity of Minnesota, Minneapolis, MN.
Christopher J O'DonnellDivision of Intramural Research, National Heart, Lung and Blood Institute (NHLBI), Framingham, MA; NHLBI's Framingham Heart Study, Framingham, MA; Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Framingham Heart Study · USNorthwestern University · USThe University of Texas Health Science Center at Houston · USNational Institutes of Health · USColumbia University · USHarbor–UCLA Medical Center · USMcGill University · CAMcGill University Health Centre · CANational Heart Lung and Blood Institute · USUniversity of California, San Diego · USUniversity of Illinois Chicago · USUniversity of Minnesota · US

Funding

Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024156 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2006 to 2011
$53.0M
Framingham Project/LevyZIAHL006001 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEVY, DANIEL · 2009 to 2025
$51.1M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
Cardiovascular Genomics and Bioinformatics projectsZIAHL006170 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI JOHNSON, ANDREW · 2013 to 2025
$25.3M
Genome-Wide Association Analysis in Essential Hypertension (FEHGAS study)R01HL086694 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ARAVINDA CHAKRAVARTI · 2007 to 2026
$21.2M
Epidemiology of Venous Thrombosis & Pulmonary EmbolismR01HL059367 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI TANG, WEIHONG · 1998 to 2024
$11.8M
Genome-Wide Association for Loci Influencing CHD and Other Heart, Lung and BloodR01HL087641 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2006 to 2008
$3.7M
GWA for Gene-Environment Interaction Effects Influencing CHDU01HG004402 · NHGRI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2007 to 2009
$1.6M
Adjunctive Use of Apyrase to Fibrinolytic TherapyR44HL095169 · NHLBI · APT THERAPEUTICS, INC. · PI CHEN, RIDONG · 2012 to 2013
$1.3M
NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1 TR001422NCRR NIH HHS UL1 RR024156NCRR NIH HHS UL1 RR025005NHGRI NIH HHS U01 HG004402NHLBI NIH HHS HHSN268200900041CNHLBI NIH HHS HHSN268201100005CNHLBI NIH HHS HHSN268201100005GNHLBI NIH HHS HHSN268201100005INHLBI NIH HHS HHSN268201100006CNHLBI NIH HHS HHSN268201100007CNHLBI NIH HHS HHSN268201100007INHLBI NIH HHS HHSN268201100008CNHLBI NIH HHS HHSN268201100008INHLBI NIH HHS HHSN268201100009CNHLBI NIH HHS HHSN268201100009INHLBI NIH HHS HHSN268201100010CNHLBI NIH HHS HHSN268201100011CNHLBI NIH HHS HHSN268201100011INHLBI NIH HHS HHSN268201100012CNHLBI NIH HHS HHSN268201300025CNHLBI NIH HHS HHSN268201300026CNHLBI NIH HHS HHSN268201300027CNHLBI NIH HHS HHSN268201300028CNHLBI NIH HHS HHSN268201300029CNHLBI NIH HHS N01 HC025195NHLBI NIH HHS N01 HC095159NHLBI NIH HHS N01 HC095169NHLBI NIH HHS R01 HL059367NHLBI NIH HHS R01 HL086694NHLBI NIH HHS R01 HL087641NIDDK NIH HHS P30 DK063491
6 · The paper itself

Abstract

backgroundMultiple genetic loci are associated with clinical cardiovascular (CV) disease and individual CV risk factors. Individuals with ideal levels of all major CV risk factors have very low risk for CV disease morbidity or mortality. Ideal levels of risk factors can be attained by lifestyle modifications; however, little is known about gene variants associated with ideal CV health. Our objective was to carry out a genome-wide association study on the trait. METHODS AND

resultsWe examined 2 dichotomous phenotypes of ideal CV health-clinical (untreated cholesterol <200 mg/dL, untreated blood pressure <120/<80, not diabetic) and clinical+behavioral (clinical plus: not a current smoker, body mass index <25 kg/m(2))-among white participants aged 50±5 years. We performed a meta-analysis of 4 genome-wide association studies (total n=11,708) from the MESA, CARDIA, ARIC, and Framingham Heart Study cohorts. We identified a single-nucleotide polymorphism (rs445925) in the APOC1/APOE region that was associated with clinical ideal CV health at genome-wide level of significance (P<2.0 × 10(-9)). The significance of this region was validated using exome chip genotyping. The association with ideal CV health was attenuated after adjusting for low-density lipoprotein cholesterol.

conclusionA common single-nucleotide polymorphism in the APOC1/APOE region, previously found to be associated with protective levels of cholesterol and lower CV risk, may be associated with ideal health. In future replication studies, larger sample sizes may be needed to detect loci with more modest effects on ideal CV health. In addition to the important impact of lifestyle modifications, we have identified evidence for gene variation that plays a role in ideal CV health.

Indexed as

Apolipoprotein C-ICardiovascular DiseasesGene Expression ProfilingGenetic LociGenome-Wide Association StudyHumansProtective FactorsAPOC1 protein, humanApolipoprotein C-I

Identifiers

PMID27179730
PMCPMC4873714
OpenAlexW2285369373

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.